286610816	286610816	CD	B-NP	O
|	|	NN	I-NP	O
GCWGH	GCWGH	NN	I-NP	O
|	|	NN	I-NP	O
49352101	49352101	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
2754147	2754147	CD	B-NP	O
|	|	CC	I-NP	O
9/10/2006	9/10/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
4/23/2006	4/23/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/1/2006	1/1/2006	CD	B-NP	O
ATTENDING	ATTENDING	NN	I-NP	O
:	:	:	O	O
VANLITH	VANLITH	NNP	B-NP	O
,	,	,	O	O
WARREN	WARREN	NNP	B-NP	O
JAME	JAME	NNP	I-NP	O
MD	MD	NNP	I-NP	O
PRIMARY	PRIMARY	NNP	I-NP	O
CARE	CARE	NNP	I-NP	O
PHYSICIAN	PHYSICIAN	NNP	I-NP	O
:	:	:	O	O
Rodrick	Rodrick	NNP	B-NP	O
Lacher	Lacher	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DIAGNOSES	DIAGNOSES	NNP	I-NP	O
:	:	:	O	O
GI	GI	NN	B-NP	O
bleed	bleed	NN	I-NP	O
,	,	,	O	O
V-fib	V-fib	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
stent	stent	JJ	I-NP	O
placement	placement	NN	I-NP	O
and	and	CC	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
ICD	ICD	NN	I-NP	O
placement	placement	NN	I-NP	O
,	,	,	O	O
CVA	CVA	NN	B-NP	B-protein
,	,	,	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
GERD	GERD	NN	B-NP	O
,	,	,	O	O
hypertension	hypertension	NN	B-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
,	,	,	O	O
status	status	NN	B-NP	B-protein
post	post	NN	I-NP	I-protein
St.	St.	NNP	I-NP	I-protein
Jude	Jude	NNP	I-NP	I-protein
's	's	POS	B-NP	I-protein
MVR	MVR	NN	I-NP	I-protein
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
,	,	,	O	O
memory	memory	NN	B-NP	O
deficit	deficit	NN	I-NP	O
,	,	,	O	O
left-sided	left-sided	JJ	B-NP	O
weakness	weakness	NN	I-NP	O
and	and	CC	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
evacuation	evacuation	NN	I-NP	O
of	of	IN	B-PP	O
left	left	JJ	B-NP	O
subdural	subdural	JJ	I-NP	O
hematoma	hematoma	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
HISTORY	HISTORY	NN	I-NP	O
OF	OF	IN	B-PP	O
PRESENT	PRESENT	JJ	B-NP	O
ILLNESS	ILLNESS	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
to	to	TO	B-PP	O
CCU	CCU	NN	B-NP	O
admission	admission	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
IMH	IMH	NN	B-NP	B-protein
on	on	IN	B-PP	O
5/25/06	5/25/06	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
behaving	behave	VBG	I-VP	O
unlike	unlike	IN	B-PP	O
himself	himself	PRP	B-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
black	black	JJ	B-NP	O
tarry	tarry	NN	I-NP	O
stools	stool	NNS	I-NP	O
for	for	IN	B-PP	O
two	two	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
found	find	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
guaiac	guaiac	JJ	B-ADJP	O
positive	positive	JJ	B-ADJP	O
.	.	.	O	O

A	A	DT	B-NP	O
head	head	NN	I-NP	O
CT	CT	NN	I-NP	O
showed	show	VBD	B-VP	O
no	no	DT	B-NP	O
new	new	JJ	I-NP	O
lesions	lesion	NNS	I-NP	O
but	but	CC	O	O
did	do	VBD	B-VP	O
show	show	VB	I-VP	O
multiple	multiple	JJ	B-NP	O
infarcts	infarct	NNS	I-NP	O
that	that	WDT	B-NP	O
were	be	VBD	B-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
old	old	JJ	B-ADJP	O
.	.	.	O	O

On	On	IN	B-PP	O
10/18/06	10/18/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
EGD	EGD	NN	I-NP	B-protein
showing	show	VBG	B-VP	O
clot	clot	NN	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
distal	distal	JJ	I-NP	O
esophagus	esophagus	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
clot	clot	NN	I-NP	O
was	be	VBD	B-VP	O
removed	remove	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
possible	possible	JJ	I-NP	O
culprit	culprit	NN	I-NP	O
vessel	vessel	NN	I-NP	O
was	be	VBD	B-VP	O
clipped	clip	VBN	I-VP	O
.	.	.	O	O

Around	Around	IN	B-PP	O
midnight	midnight	NN	B-NP	O
on	on	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
became	become	VBD	B-VP	O
borderline	borderline	JJ	B-NP	O
hypertension	hypertension	NN	I-NP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
unclear	unclear	JJ	I-NP	O
reason	reason	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
was	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
ACE	ACE	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
and	and	CC	I-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
were	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
Lasix	Lasix	NN	I-NP	O
was	be	VBD	B-VP	O
held	hold	VBN	I-VP	O
.	.	.	O	O

On	On	IN	B-PP	O
8/19/06	8/19/06	CD	B-NP	O
at	at	IN	B-PP	O
around	around	RB	B-NP	O
4	4	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
reportedly	reportedly	RB	I-VP	O
having	have	VBG	I-VP	O
fitful	fitful	JJ	B-NP	O
sleeping	sleeping	NN	I-NP	O
and	and	CC	O	O
went	go	VBD	B-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
bathroom	bathroom	NN	I-NP	O
.	.	.	O	O

Soon	Soon	RB	B-ADVP	O
afterwards	afterwards	RB	I-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
nurse	nurse	NN	I-NP	O
noticed	notice	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
having	have	VBG	I-VP	O
more	more	JJR	B-NP	O
ectopy	ectopy	NN	I-NP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

Soon	Soon	RB	B-PP	O
after	after	IN	I-PP	O
4	4	CD	B-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
a.m.	a.m.	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
either	either	CC	I-VP	O
found	find	VBD	I-VP	O
unresponsive	unresponsive	JJ	B-NP	O
or	or	CC	I-NP	O
ventricular	ventricular	JJ	I-NP	O
fibrillation	fibrillation	NN	I-NP	O
was	be	VBD	B-VP	O
seen	see	VBN	I-VP	O
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
and	and	CC	O	O
a	a	DT	B-NP	O
code	code	NN	I-NP	O
was	be	VBD	B-VP	O
called	call	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
rhythm	rhythm	NN	I-NP	O
was	be	VBD	B-VP	O
shown	show	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
V-fib	V-fib	JJ	B-ADJP	O
.	.	.	O	O

Chest	Chest	NNP	B-NP	O
compressions	compression	NNS	I-NP	O
were	be	VBD	B-VP	O
initiated	initiate	VBN	I-VP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
shocked	shock	VBN	I-VP	O
.	.	.	O	O

Soon	Soon	RB	B-ADVP	O
thereafter	thereafter	RB	I-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
two	two	CD	B-NP	O
more	more	JJR	I-NP	O
shock	shock	NN	I-NP	O
episodes	episode	NNS	I-NP	O
for	for	IN	B-PP	O
V-fib	V-fib	NN	B-NP	B-protein
and	and	CC	O	O
was	be	VBD	B-VP	O
loaded	load	VBN	I-VP	O
on	on	IN	B-PP	O
amiodarone	amiodarone	NN	B-NP	B-protein
300	300	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
IV	IV	CD	B-NP	I-protein
x1	x1	NN	I-NP	I-protein
.	.	.	O	O

Soon	Soon	RB	B-ADVP	O
thereafter	thereafter	RB	I-ADVP	O
,	,	,	O	O
his	his	PRP$	B-NP	O
V-fib	V-fib	NN	I-NP	B-protein
terminated	terminate	VBN	B-VP	O
and	and	CC	O	O
subsequently	subsequently	RB	B-ADVP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
slow	slow	JJ	B-NP	O
PEA	PEA	NN	I-NP	O
treated	treat	VBN	B-VP	O
with	with	IN	B-PP	O
atropine	atropine	NN	B-NP	O
,	,	,	I-NP	O
epinephrine	epinephrine	NN	I-NP	O
,	,	,	I-NP	O
calcium	calcium	NN	I-NP	O
and	and	CC	I-NP	O
magnesium	magnesium	NN	I-NP	O
.	.	.	O	O

Code	Code	NN	B-NP	O
labs	lab	NNS	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
potassium	potassium	NN	I-NP	O
of	of	IN	B-PP	O
3.3	3.3	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
intubated	intubate	VBN	I-VP	O
.	.	.	O	O

A	A	DT	B-NP	O
left	left	JJ	I-NP	B-cell_line
femoral	femoral	JJ	I-NP	I-cell_line
line	line	NN	I-NP	I-cell_line
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transported	transport	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
with	with	IN	B-PP	O
stable	stable	JJ	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
on	on	IN	B-PP	O
neosynephrine	neosynephrine	NN	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
easily	easily	RB	I-VP	O
weaned	wean	VBN	I-VP	O
off	off	RP	B-PRT	O
neosynephrine	neosynephrine	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
does	do	VBZ	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
any	any	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
arrhythmia	arrhythmia	NN	I-NP	O
.	.	.	O	O

PAST	PAST	NNP	B-NP	O
MEDICAL	MEDICAL	NNP	I-NP	O
HISTORY	HISTORY	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
past	past	JJ	I-NP	O
medical	medical	JJ	I-NP	O
history	history	NN	I-NP	O
is	be	VBZ	B-VP	O
significant	significant	JJ	B-ADJP	O
for	for	IN	B-PP	O
:	:	:	O	O
;	;	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
CABG	CABG	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
SVG	SVG	NN	I-NP	O
to	to	TO	B-PP	O
RCA	RCA	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
with	with	IN	B-PP	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
in	in	IN	B-PP	O
1999	1999	CD	B-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
2003	2003	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
LAD	LAD	NN	I-NP	O
and	and	CC	I-NP	O
D1	D1	NN	I-NP	O
were	be	VBD	B-VP	O
stented	stente	VBN	I-VP	O
.	.	.	O	O

In	In	IN	B-PP	O
2004	2004	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
underwent	undergo	VBD	B-VP	O
catheterization	catheterization	NN	B-NP	O
for	for	IN	B-PP	O
unstable	unstable	JJ	B-NP	O
angina	angina	NN	I-NP	O
showing	show	VBG	B-VP	O
restenosis	restenosis	NN	B-NP	O
of	of	IN	B-PP	O
D1	D1	NN	B-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
re-stented	re-stented	JJ	B-ADJP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Ischemic	Ischemic	JJ	B-NP	O
cardiomyopathy	cardiomyopathy	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

CVA	CVA	NN	B-NP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Seizure	Seizure	NN	B-NP	O
disorder	disorder	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Subdural	Subdural	JJ	B-NP	O
hematoma	hematoma	NN	I-NP	O
while	while	IN	B-SBAR	O
on	on	IN	B-PP	O
Coumadin	Coumadin	NN	B-NP	O
,	,	,	O	O
status	status	NN	B-NP	O
post	post	NN	I-NP	O
burr	burr	NN	I-NP	O
hole	hole	NN	I-NP	O
evacuation	evacuation	NN	I-NP	O
.	.	.	O	O

MEDICATIONS	MEDICATIONS	NNS	B-NP	O
PRIOR	PRIOR	NN	I-NP	O
TO	TO	TO	B-VP	O
ADMISSION	ADMISSION	NN	I-VP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
medications	medication	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
admission	admission	NN	B-NP	O
included	include	VBD	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Lasix	Lasix	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
200	200	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
80	80	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Keppra	Keppra	NNP	B-NP	O
1	1	CD	I-NP	O
g	g	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
5	5	CD	I-NP	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
81	81	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

TriCor	TriCor	NN	B-NP	O
145	145	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Zestril	Zestril	NNP	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
9	9	CD	I-NP	O
.	.	.	O	O

Prilosec	Prilosec	NNP	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	O
70	70	CD	I-NP	O
mg	mg	NN	I-NP	O
subcutaneous	subcutaneous	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
44	44	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	B-NP	O
12	12	CD	I-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
12	12	CD	I-NP	O
units	unit	NNS	I-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
SOCIAL	SOCIAL	NN	I-NP	O
HISTORY	HISTORY	NN	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
not	not	RB	I-VP	O
known	know	VBN	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
a	a	DT	B-NP	O
smoker	smoker	NN	I-NP	O
or	or	CC	O	O
to	to	TO	B-VP	O
use	use	VB	I-VP	O
alcohol	alcohol	NN	B-NP	O
.	.	.	O	O

ALLERGIES	ALLERGIES	NNS	B-NP	O
:	:	:	O	O
desquamating	desquamate	VBG	B-VP	O
rash	rash	NN	B-NP	O
to	to	TO	B-PP	O
phenytoin	phenytoin	NN	B-NP	O
and	and	CC	O	O
also	also	RB	B-ADVP	O
a	a	DT	B-NP	O
possible	possible	JJ	I-NP	O
allergy	allergy	NN	I-NP	O
to	to	TO	B-PP	O
Ancef	Ancef	NN	B-NP	O
which	which	WDT	B-NP	O
occurred	occur	VBD	B-VP	O
during	during	IN	B-PP	O
this	this	DT	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
ON	ON	NN	I-NP	O
ADMISSION	ADMISSION	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
admission	admission	NN	B-NP	O
on	on	IN	B-PP	O
10/20/06	10/20/06	CD	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
vital	vital	JJ	I-NP	O
signs	sign	NNS	I-NP	O
were	be	VBD	B-VP	O
temperature	temperature	NN	B-NP	O
98.3	98.3	CD	I-NP	O
,	,	,	O	O
pulse	pulse	NN	B-NP	O
86	86	CD	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
122/73	122/73	CD	I-NP	O
,	,	,	O	O
respiratory	respiratory	JJ	B-NP	O
rate	rate	NN	I-NP	O
16	16	CD	I-NP	O
,	,	,	O	O
O2	O2	NN	B-NP	O
sat	sit	VBD	B-VP	O
97	97	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
not	not	RB	O	O
in	in	IN	B-PP	O
any	any	DT	B-NP	O
acute	acute	JJ	I-NP	O
distress	distress	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
alert	alert	JJ	B-NP	O
and	and	CC	I-NP	O
oriented	orient	VBN	I-NP	O
x3	x3	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
interactive	interactive	JJ	B-ADJP	O
and	and	CC	I-ADJP	O
appropriate	appropriate	JJ	I-ADJP	O
.	.	.	O	O

Skin	Skin	NNP	B-NP	O
was	be	VBD	B-VP	O
normal	normal	JJ	B-ADJP	O
.	.	.	O	O

HEENT	HEENT	NN	B-NP	O
showed	show	VBD	B-VP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
left-sided	left-sided	JJ	I-NP	O
facial	facial	JJ	I-NP	O
droop	droop	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
unchanged	unchanged	JJ	B-ADJP	O
per	per	IN	B-PP	O
patient	patient	NN	B-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
family	family	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
JVP	JVP	NN	I-NP	B-protein
was	be	VBD	B-VP	O
6	6	CD	B-NP	O
cm	cm	NN	I-NP	O
.	.	.	O	O

There	There	EX	B-NP	O
was	be	VBD	B-VP	O
no	no	DT	B-NP	O
lymphadenopathy	lymphadenopathy	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
chest	chest	NN	I-NP	O
was	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
S1	S1	NN	I-NP	B-protein
and	and	CC	O	O
normal	normal	JJ	B-ADJP	O
S2	S2	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
extra	extra	JJ	I-NP	O
sounds	sound	NNS	I-NP	O
or	or	CC	I-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

Abdominal	Abdominal	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
benign	benign	JJ	B-ADJP	O
.	.	.	O	O

Extremities	Extremity	NNS	B-NP	O
had	have	VBD	B-VP	O
2	2	CD	B-NP	O
+	+	SYM	I-NP	O
pulses	pulse	NNS	I-NP	O
without	without	IN	B-PP	O
clubbing	clubbing	NN	B-NP	O
,	,	,	I-NP	O
cyanosis	cyanosis	NN	I-NP	O
or	or	CC	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Neurological	Neurological	JJ	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
a	a	DT	B-NP	O
left-sided	left-sided	JJ	I-NP	O
facial	facial	JJ	I-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
.	.	.	O	O

Otherwise	Otherwise	RB	B-ADVP	O
,	,	,	O	O
cranial	cranial	JJ	B-NP	O
nerves	nerve	NNS	I-NP	O
II	II	CD	B-NP	O
through	through	IN	B-PP	O
XII	XII	NN	B-NP	B-DNA
were	be	VBD	B-VP	O
intact	intact	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
4/5	4/5	CD	B-NP	O
strength	strength	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
side	side	NN	I-NP	O
,	,	,	O	O
5/5	5/5	CD	B-NP	O
strength	strength	NN	I-NP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
right	right	JJ	I-NP	O
side	side	NN	I-NP	O
.	.	.	O	O

Toes	Toe	NNS	B-NP	O
were	be	VBD	B-VP	O
downgoing	downgoe	VBG	I-VP	O
.	.	.	O	O

ADMISSION	ADMISSION	NN	B-NP	O
LABS	LABS	NN	I-NP	O
:	:	:	O	O
Labs	Lab	NNS	B-NP	B-protein
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
were	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.7	1.7	CD	B-NP	O
,	,	,	O	O
glucose	glucose	NN	B-NP	O
of	of	IN	B-PP	O
237	237	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
37	37	CD	B-NP	O
.	.	.	O	O

OPERATIONS	OPERATIONS	NNS	B-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
10/18/06	10/18/06	CD	B-NP	O
,	,	,	O	O
elective	elective	JJ	B-NP	O
inpatient	inpatient	NN	I-NP	O
EGD	EGD	NN	I-NP	O
for	for	IN	B-PP	O
heme-positive	heme-positive	JJ	B-NP	O
black	black	JJ	I-NP	O
stool	stool	NN	I-NP	O
performed	perform	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Marlin	Marlin	NNP	I-NP	O
Shigo	Shigo	NNP	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
presence	presence	NN	I-NP	O
of	of	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Val	Val	NNP	I-NP	O
Blache	Blache	NNP	I-NP	O
On	On	IN	B-PP	O
11/16/06	11/16/06	CD	B-NP	O
,	,	,	O	O
urgent	urgent	JJ	B-NP	O
cardiac	cardiac	JJ	I-NP	O
cathet1erization	cathet1erization	NN	I-NP	O
for	for	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
performed	perform	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Monte	Monte	NNP	I-NP	O
Lenig	Lenig	NNP	I-NP	O
with	with	IN	B-PP	O
stent	stent	JJ	B-NP	O
placement	placement	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
4/22/06	4/22/06	CD	B-NP	O
,	,	,	O	O
dual	dual	JJ	B-NP	O
chamber	chamber	NN	I-NP	O
ICD	ICD	NN	I-NP	O
placed	place	VBN	B-VP	O
by	by	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Danni	Danni	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
BY	BY	NNP	I-NP	O
PROBLEM	PROBLEM	NNP	I-NP	O
:	:	:	O	O
This	This	DT	B-NP	O
is	be	VBZ	B-VP	O
a	a	DT	B-NP	O
66-year-old	66-year-old	JJ	I-NP	O
man	man	NN	I-NP	O
with	with	IN	B-PP	O
coronary	coronary	JJ	B-NP	O
artery	artery	NN	I-NP	O
disease	disease	NN	I-NP	O
and	and	CC	O	O
mitral	mitral	JJ	B-NP	O
valve	valve	NN	I-NP	O
replacement	replacement	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
initially	initially	RB	I-VP	O
admitted	admit	VBN	I-VP	O
for	for	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
then	then	RB	I-VP	O
admitted	admit	VBN	I-VP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	O
status	status	NN	I-NP	O
post	post	NN	I-NP	O
V-fib	V-fib	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	O	O
found	find	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
NSTEMI	NSTEMI	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
course	course	NN	I-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
CCU	CCU	NN	I-NP	B-DNA
was	be	VBD	B-VP	O
as	as	IN	B-SBAR	O
follows	follow	VBZ	B-VP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Cardiovascular	Cardiovascular	NNP	B-NP	O
:	:	:	O	O
A.	A.	NNP	B-NP	O
Ischemia	Ischemia	NNP	I-NP	O
:	:	:	O	O
NSTEMI	NSTEMI	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
troponin	troponin	NN	I-NP	O
elevation	elevation	NN	I-NP	O
beginning	begin	VBG	B-VP	O
15	15	CD	B-NP	O
minutes	minute	NNS	I-NP	O
after	after	IN	B-PP	O
a	a	DT	B-NP	O
code	code	NN	I-NP	O
was	be	VBD	B-VP	O
started	start	VBN	I-VP	O
,	,	,	O	O
suggesting	suggest	VBG	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
NSTEMI	NSTEMI	NN	I-NP	O
occurred	occur	VBD	B-VP	O
and	and	CC	O	O
then	then	RB	O	O
caused	cause	VBD	B-VP	O
V-fib	V-fib	JJ	B-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
peak	peak	JJ	I-NP	O
troponin	troponin	NN	I-NP	O
was	be	VBD	B-VP	O
111	111	CD	B-NP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
catheterization	catheterization	NN	I-NP	O
showed	show	VBD	B-VP	O
severe	severe	JJ	B-NP	O
3-4	3-4	CD	I-NP	O
vessel	vessel	NN	I-NP	O
disease	disease	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
occlusion	occlusion	NN	B-NP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
SVG	SVG	NN	I-NP	O
graft	graft	NN	I-NP	O
.	.	.	O	O

Two	Two	CD	B-NP	O
drug-eluting	drug-eluting	JJ	I-NP	O
stents	stent	NNS	I-NP	O
were	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
left	left	JJ	I-NP	O
circumflex	circumflex	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
treated	treat	VBN	I-VP	O
with	with	IN	B-PP	O
aspirin	aspirin	NN	B-NP	O
,	,	,	O	O
Plavix	Plavix	NN	B-NP	O
,	,	,	O	O
beta-blocker	beta-blocker	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
ACE	ACE	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
beta-blocker	beta-blocker	NN	I-NP	O
and	and	CC	I-NP	O
ACE	ACE	NN	I-NP	O
doses	dose	NNS	I-NP	O
were	be	VBD	B-VP	O
titrated	titrate	VBN	I-VP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospital	hospital	NN	I-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
taken	take	VBN	I-VP	O
off	off	RP	B-PRT	O
of	of	IN	B-PP	O
Lipitor	Lipitor	NNP	B-NP	O
briefly	briefly	NN	I-NP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
concern	concern	NN	B-NP	O
about	about	IN	B-PP	O
his	his	PRP$	B-NP	O
liver	liver	NN	I-NP	O
function	function	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
doses	dose	NNS	I-NP	O
of	of	IN	B-PP	O
Lipitor	Lipitor	NN	B-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
Fibrate	Fibrate	NNP	I-NP	O
.	.	.	O	O

B.	B.	NNP	B-NP	O
Pump	Pump	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
congestive	congestive	JJ	B-NP	O
heart	heart	NN	I-NP	O
failure	failure	NN	I-NP	O
causing	cause	VBG	B-VP	O
pulmonary	pulmonary	JJ	B-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

By	By	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
ejection	ejection	NN	I-NP	O
fraction	fraction	NN	I-NP	O
of	of	IN	B-PP	O
25-30	25-30	CD	B-NP	O
%	%	NN	I-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
moderately	moderately	RB	I-NP	O
dilated	dilated	JJ	I-NP	O
left	left	JJ	I-NP	O
ventricle	ventricle	NN	I-NP	O
,	,	,	O	O
severe	severe	JJ	B-NP	O
global	global	JJ	I-NP	O
hypokinesis	hypokinesis	NN	I-NP	O
with	with	IN	B-PP	O
posterior	posterior	JJ	B-NP	O
and	and	CC	I-NP	O
inferior	inferior	JJ	I-NP	O
akinesis	akinesis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
diuresed	diurese	VBN	B-VP	O
well	well	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
CCU	CCU	NN	I-NP	O
stay	stay	NN	I-NP	O
and	and	CC	B-PP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
floor	floor	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	B-protein
I	I	NN	I-NP	I-protein
's	's	POS	B-NP	O
and	and	CC	O	O
O	O	NNP	B-NP	O
's	's	POS	B-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
net	net	JJ	B-NP	O
negative	negative	JJ	I-NP	O
,	,	,	O	O
and	and	CC	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
at	at	IN	B-PP	O
a	a	DT	B-NP	O
weight	weight	NN	I-NP	O
of	of	IN	B-PP	O
87	87	CD	B-NP	O
kilos	kilo	NNS	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
an	an	DT	B-NP	O
echo	echo	NN	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
for	for	IN	B-PP	O
dyssynchrony	dyssynchrony	NN	B-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
echo	echo	NN	I-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
find	find	VB	I-VP	O
significant	significant	JJ	B-NP	O
evidence	evidence	NN	I-NP	O
of	of	IN	B-PP	O
dyssynchrony	dyssynchrony	NN	B-NP	O
.	.	.	O	O

C.	C.	NNP	B-NP	O
Rhythm	Rhythm	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
V-fib	V-fib	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
and	and	CC	O	O
returned	return	VBD	B-VP	O
to	to	TO	B-PP	O
normal	normal	JJ	B-NP	O
sinus	sinus	NN	I-NP	O
rhythm	rhythm	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
received	receive	VBD	B-VP	O
an	an	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
load	load	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
amiodarone	amiodarone	NN	B-NP	O
400	400	CD	I-NP	O
mg	mg	NN	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
.	.	.	O	O

After	After	IN	B-SBAR	O
he	he	PRP	B-NP	O
stabilized	stabilize	VBD	B-VP	O
,	,	,	O	O
the	the	DT	B-NP	O
amiodarone	amiodarone	NN	I-NP	O
was	be	VBD	B-VP	O
discontinued	discontinue	VBN	I-VP	O
after	after	IN	B-PP	O
AICD	AICD	NN	B-NP	O
implantation	implantation	NN	I-NP	O
on	on	IN	B-PP	O
on	on	IN	B-PP	O
7/1/06	7/1/06	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
implantation	implantation	NN	I-NP	O
itself	itself	PRP	B-NP	O
was	be	VBD	B-VP	O
uncomplicated	uncomplicated	JJ	B-ADJP	O
though	though	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
developed	develop	VBD	B-VP	O
hives	hive	NNS	B-NP	O
thought	think	VBN	B-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
due	due	IN	B-PP	O
to	to	TO	B-PP	O
administration	administration	NN	B-NP	O
of	of	IN	B-PP	O
prophylactic	prophylactic	JJ	B-NP	O
Ancef	Ancef	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
vancomycin	vancomycin	NN	B-NP	O
for	for	IN	B-PP	O
prophylaxis	prophylaxis	NN	B-NP	O
,	,	,	O	O
followed	follow	VBN	B-VP	O
by	by	IN	B-PP	O
po	po	NN	B-NP	O
clindamycin	clindamycin	NN	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
allergic	allergic	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
one	one	CD	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
IV	IV	CD	B-NP	O
Benadryl	Benadryl	NN	I-NP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

GI	GI	LS	B-LST	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
came	come	VBD	B-VP	O
in	in	RP	B-PRT	O
with	with	IN	B-PP	O
an	an	DT	B-NP	O
upper	upper	JJ	I-NP	O
GI	GI	NN	I-NP	O
bleed	bleed	NN	I-NP	O
.	.	.	O	O

A	A	DT	B-NP	O
bleeding	bleed	VBG	I-NP	O
vessel	vessel	NN	I-NP	O
at	at	IN	B-PP	O
the	the	DT	B-NP	O
GE	GE	NNP	I-NP	O
junction	junction	NN	I-NP	O
was	be	VBD	B-VP	O
clipped	clip	VBN	I-VP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
had	have	VBD	B-VP	O
a	a	DT	B-NP	O
transient	transient	JJ	I-NP	O
LFT	LFT	NN	I-NP	O
elevation	elevation	NN	I-NP	O
consistent	consistent	JJ	B-ADJP	O
with	with	IN	B-PP	O
shock	shock	NN	B-NP	O
liver	liver	NN	I-NP	O
.	.	.	O	O

LFTs	LFT	NNS	B-NP	O
were	be	VBD	B-VP	O
followed	follow	VBN	I-VP	O
and	and	CC	O	O
declined	decline	VBD	B-VP	O
appropriately	appropriately	RB	B-ADVP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
hospitalization	hospitalization	NN	I-NP	O
and	and	CC	O	O
normalized	normalize	VBN	B-VP	O
before	before	IN	B-PP	O
discharge	discharge	NN	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
proton	proton	NN	I-NP	O
pump	pump	NN	I-NP	O
inhibitor	inhibitor	NN	I-NP	O
during	during	IN	B-PP	O
his	his	PRP$	B-NP	O
stay	stay	NN	I-NP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Hematocrit	Hematocrit	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
transfused	transfuse	VBN	I-VP	O
two	two	CD	B-NP	O
units	unit	NNS	I-NP	O
of	of	IN	B-PP	O
red	red	JJ	B-NP	B-cell_type
blood	blood	NN	I-NP	I-cell_type
cells	cell	NNS	I-NP	I-cell_type
on	on	IN	B-PP	O
4/12/06	4/12/06	CD	B-NP	O
and	and	CC	I-NP	O
9/28/06	9/28/06	CD	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
hematocrit	hematocrit	NN	I-NP	O
remained	remain	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
therafter	therafter	RB	B-ADVP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
taking	take	VBG	I-VP	O
Lovenox	Lovenox	NNP	B-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	O
for	for	IN	B-PP	O
protection	protection	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
mechanical	mechanical	JJ	I-NP	O
mitral	mitral	JJ	I-NP	O
valve	valve	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
the	the	DT	B-NP	O
peri-procedure	peri-procedure	JJ	I-NP	O
period	period	NN	I-NP	O
for	for	IN	B-PP	O
his	his	PRP$	B-NP	O
ICD	ICD	NN	I-NP	O
implantation	implantation	NN	I-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
switched	switch	VBN	I-VP	O
to	to	TO	B-PP	O
heparin	heparin	NN	B-NP	O
drip	drip	NN	I-NP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
heparin	heparin	NN	I-NP	O
drip	drip	NN	I-NP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
days	day	NNS	I-NP	O
after	after	IN	B-PP	O
device	device	NN	B-NP	O
implantation	implantation	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
that	that	DT	B-NP	O
time	time	NN	I-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
restarted	restart	VBN	I-VP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatient	outpatient	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
Lovenox	Lovenox	NN	B-NP	B-protein
70	70	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-NP	I-protein
4	4	CD	I-NP	I-protein
.	.	.	O	O

Neuro	Neuro	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
a	a	DT	B-NP	O
history	history	NN	I-NP	O
of	of	IN	B-PP	O
CVA	CVA	NN	B-NP	B-protein
with	with	IN	B-PP	O
a	a	DT	B-NP	O
residual	residual	JJ	I-NP	O
left	left	JJ	I-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
.	.	.	O	O

These	These	DT	B-NP	O
symptoms	symptom	NNS	I-NP	O
were	be	VBD	B-VP	O
stable	stable	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
also	also	RB	I-VP	O
seen	see	VBN	I-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
Psychiatry	Psychiatry	NNP	I-NP	O
Service	Service	NNP	I-NP	O
to	to	TO	B-VP	O
evaluate	evaluate	VB	I-VP	O
his	his	PRP$	B-NP	O
memory	memory	NN	I-NP	O
deficits	deficit	NNS	I-NP	O
and	and	CC	I-NP	O
abilities	ability	NNS	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
decisions	decision	NNS	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
Psychiatry	Psychiatry	NNP	I-NP	O
team	team	NN	I-NP	O
recommended	recommend	VBD	B-VP	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
followed	follow	VBN	I-VP	O
by	by	IN	B-PP	O
Neurology	Neurology	NN	B-NP	O
after	after	IN	B-PP	O
discharge	discharge	NN	B-NP	O
and	and	CC	O	O
that	that	IN	B-SBAR	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
be	be	VB	B-VP	O
considered	consider	VBN	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
formal	formal	JJ	I-NP	O
neuropsychiatric	neuropsychiatric	JJ	I-NP	O
testing	testing	NN	I-NP	O
for	for	IN	B-PP	O
evaluation	evaluation	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
neurologic	neurologic	JJ	I-NP	O
and	and	CC	I-NP	O
cognitive	cognitive	JJ	I-NP	O
deficits	deficit	NNS	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Pulmonary	Pulmonary	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
pulmonary	pulmonary	JJ	I-NP	O
edema	edema	NN	I-NP	O
resolved	resolve	VBN	B-VP	O
with	with	IN	B-PP	O
diuresis	diuresis	NN	B-NP	O
.	.	.	O	O

6	6	CD	B-NP	O
.	.	.	O	O

ID	ID	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
presented	present	VBD	B-VP	O
with	with	IN	B-PP	O
fever	fever	NN	B-NP	O
and	and	CC	O	O
an	an	DT	B-NP	O
elevated	elevate	VBN	I-NP	O
white	white	JJ	I-NP	O
blood	blood	NN	I-NP	O
cell	cell	NN	I-NP	O
count	count	NN	I-NP	O
initially	initially	RB	B-ADVP	O
and	and	CC	O	O
a	a	DT	B-NP	O
question	question	NN	I-NP	O
of	of	IN	B-PP	O
an	an	DT	B-NP	O
infiltrate	infiltrate	NN	I-NP	O
on	on	IN	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
.	.	.	O	O

This	This	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
covered	cover	VBN	I-VP	O
with	with	IN	B-PP	O
levofloxacin	levofloxacin	NN	B-NP	O
and	and	CC	I-NP	O
Flagyl	Flagyl	NN	I-NP	O
for	for	IN	B-PP	O
three	three	CD	B-NP	O
days	day	NNS	I-NP	O
empirically	empirically	RB	B-ADVP	O
for	for	IN	B-PP	O
aspiration	aspiration	NN	B-NP	O
pneumonia	pneumonia	NN	I-NP	O
.	.	.	O	O

During	During	IN	B-PP	O
hospitalization	hospitalization	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
did	do	VBD	B-VP	O
have	have	VB	I-VP	O
very	very	RB	B-NP	O
transient	transient	JJ	I-NP	O
low-grade	low-grade	JJ	I-NP	O
temperatures	temperature	NNS	I-NP	O
on	on	IN	B-PP	O
two	two	CD	B-NP	O
other	other	JJ	I-NP	O
occasions	occasion	NNS	I-NP	O
.	.	.	O	O

Cultures	Culture	NNS	B-NP	O
including	include	VBG	B-PP	O
chest	chest	NN	B-NP	O
x-ray	x-ray	NN	I-NP	O
,	,	,	O	O
urine	urine	NN	B-NP	O
and	and	CC	I-NP	O
blood	blood	NN	I-NP	O
cultures	culture	NNS	I-NP	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

As	As	IN	B-PP	O
of	of	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
dictation	dictation	NN	I-NP	O
,	,	,	O	O
C.	C.	FW	B-NP	O
difficile	difficile	FW	I-NP	O
tests	test	NNS	I-NP	O
were	be	VBD	B-VP	O
also	also	RB	B-ADVP	O
negative	negative	JJ	B-ADJP	O
.	.	.	O	O

7	7	CD	B-NP	O
.	.	.	O	O

Renal	Renal	JJ	B-ADJP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
was	be	VBD	B-VP	O
elevated	elevate	VBN	I-VP	O
reaching	reach	VBG	I-VP	O
a	a	DT	B-NP	O
peak	peak	NN	I-NP	O
of	of	IN	B-PP	O
1.9	1.9	CD	B-NP	O
on	on	IN	B-PP	O
4/12/06	4/12/06	CD	B-NP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
setting	setting	NN	I-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
cardiac	cardiac	JJ	I-NP	O
arrest	arrest	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
creatinine	creatinine	NN	I-NP	O
normalized	normalize	VBD	B-VP	O
and	and	CC	O	O
on	on	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
was	be	VBD	B-VP	O
1.2	1.2	CD	B-NP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

Nutrition	Nutrition	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
evaluated	evaluate	VBN	I-VP	O
by	by	IN	B-PP	O
Speech	Speech	NN	B-NP	O
and	and	CC	I-NP	O
Swallow	Swallow	NN	I-NP	O
.	.	.	O	O

Initially	Initially	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
put	put	VBN	I-VP	O
on	on	IN	B-PP	O
a	a	DT	B-NP	O
puree-thin	puree-thin	JJ	I-NP	O
diet	diet	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
advanced	advance	VBN	I-VP	O
to	to	TO	B-PP	O
mechanical	mechanical	JJ	B-NP	O
soft	soft	JJ	I-NP	O
and	and	CC	I-NP	O
thin	thin	JJ	I-NP	O
liquids	liquid	NNS	I-NP	O
prior	prior	JJ	B-ADJP	O
to	to	TO	B-VP	O
discharge	discharge	VB	I-VP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Endocrine	Endocrine	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
diabetic	diabetic	JJ	B-ADJP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
NPH	NPH	NN	B-NP	B-protein
22	22	CD	B-NP	I-protein
units	unit	NNS	I-NP	I-protein
b.i.d.	b.i.d.	RB	B-ADVP	O
and	and	CC	O	O
a	a	DT	B-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
the	the	DT	B-NP	O
time	time	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
blood	blood	NN	I-NP	O
sugars	sugar	NNS	I-NP	O
were	be	VBD	B-VP	O
well	well	RB	I-VP	O
controlled	control	VBN	I-VP	O
.	.	.	O	O

He	He	PRP	B-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
on	on	IN	B-PP	O
Lantus	Lantus	NNP	B-NP	O
48	48	CD	I-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
-LRB-	-LRB-	HYPH	O	O
a	a	DT	B-NP	O
light	light	JJ	I-NP	O
increase	increase	NN	I-NP	O
over	over	IN	B-PP	O
his	his	PRP$	B-NP	O
outpatinet	outpatinet	NN	I-NP	B-protein
dose	dose	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
a	a	DT	B-NP	O
NovoLog	NovoLog	NNP	I-NP	O
sliding	slide	VBG	I-NP	O
scale	scale	NN	I-NP	O
for	for	IN	B-PP	O
coverage	coverage	NN	B-NP	O
during	during	IN	B-PP	O
meals	meal	NNS	B-NP	O
.	.	.	O	O

PHYSICAL	PHYSICAL	NN	B-NP	O
EXAMINATION	EXAMINATION	NN	I-NP	O
AT	AT	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
:	:	:	O	O
On	On	IN	B-PP	O
the	the	DT	B-NP	O
day	day	NN	I-NP	O
of	of	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
the	the	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
afebrile	afebrile	JJ	B-ADJP	O
.	.	.	O	O

Heart	Heart	NN	B-NP	O
rate	rate	NN	I-NP	O
70-80s	70-80	NNS	I-NP	O
,	,	,	O	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
90-120/66	90-120/66	CD	B-NP	O
-70	-70	CD	I-NP	O
.	.	.	O	O

Oxygen	Oxygen	NN	B-NP	O
saturation	saturation	NN	I-NP	O
96-98	96-98	CD	B-NP	O
%	%	NN	I-NP	O
on	on	IN	B-PP	O
room	room	NN	B-NP	O
air	air	NN	I-NP	O
.	.	.	O	O

Weight	Weight	NN	B-NP	O
87	87	CD	B-NP	O
kilograms	kilogram	NNS	I-NP	O
.	.	.	O	O

Pertinent	Pertinent	JJ	B-NP	B-protein
labs	lab	NNS	I-NP	I-protein
include	include	VBP	B-VP	O
a	a	DT	B-NP	O
creatinine	creatinine	NN	I-NP	O
of	of	IN	B-PP	O
1.2	1.2	CD	B-NP	O
,	,	,	O	O
hematocrit	hematocrit	NN	B-NP	O
of	of	IN	B-PP	O
36	36	CD	B-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
's	's	POS	B-NP	O
exam	exam	NN	I-NP	O
showed	show	VBD	B-VP	O
continuing	continue	VBG	I-VP	O
left	left	JJ	B-NP	O
facial	facial	JJ	I-NP	O
hemiparesis	hemiparesis	NN	I-NP	O
.	.	.	O	O

Lungs	Lung	NNS	B-NP	O
were	be	VBD	B-VP	O
clear	clear	JJ	B-ADJP	O
.	.	.	O	O

Cardiac	Cardiac	JJ	B-NP	O
exam	exam	NN	I-NP	O
was	be	VBD	B-VP	O
notable	notable	JJ	B-ADJP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
mechanical	mechanical	JJ	I-NP	O
S1	S1	NN	I-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
extra	extra	JJ	I-NP	O
sounds	sound	NNS	I-NP	O
or	or	CC	I-NP	O
murmurs	murmur	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
abdomen	abdoman	NNS	I-NP	O
was	be	VBD	B-VP	O
soft	soft	JJ	B-ADJP	O
,	,	,	O	O
and	and	CC	O	O
the	the	DT	B-NP	O
ICD	ICD	NN	I-NP	B-DNA
placement	placement	NN	I-NP	I-DNA
site	site	NN	I-NP	I-DNA
was	be	VBD	B-VP	O
well	well	RB	I-VP	O
healed	heal	VBN	I-VP	O
without	without	IN	B-PP	O
swelling	swelling	NN	B-NP	O
,	,	,	I-NP	O
tenderness	tenderness	NN	I-NP	O
or	or	CC	I-NP	O
erythema	erythema	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
1	1	LS	B-LST	O
.	.	.	O	O

Aspirin	Aspirin	NN	B-NP	O
325	325	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

2	2	LS	B-LST	O
.	.	.	O	O

Lipitor	Lipitor	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

3	3	LS	B-LST	O
.	.	.	O	O

Plavix	Plavix	NN	B-NP	O
75	75	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

4	4	LS	B-LST	O
.	.	.	O	O

Benadryl	Benadryl	NN	B-NP	O
25-50	25-50	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
itch	itch	NN	I-NP	O
.	.	.	O	O

5	5	LS	B-LST	O
.	.	.	O	O

Colace	Colace	NNP	B-NP	O
100	100	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
6	6	CD	I-NP	O
.	.	.	O	O

Lovenox	Lovenox	NN	B-NP	B-protein
70	70	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
subcutaneous	subcutaneous	JJ	I-NP	I-protein
b.i.d.	b.i.d.	NN	I-NP	I-protein
7	7	CD	I-NP	I-protein
.	.	.	O	O

TriCor	TriCor	NN	B-NP	O
145	145	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

8	8	CD	B-NP	O
.	.	.	O	O

NovoLog	NovoLog	NN	B-NP	O
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
q.a.c.	q.a.c.	NN	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
125	125	CD	B-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
zero	zero	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
125-150	125-150	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
2	2	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
151-200	151-200	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
3	3	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
200-250	200-250	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
4	4	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
251-300	251-300	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
6	6	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
301-350	301-350	CD	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
8	8	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

If	If	IN	B-SBAR	O
blood	blood	NN	B-NP	O
sugar	sugar	NN	I-NP	O
351-400	351-400	CD	B-NP	O
or	or	CC	I-NP	O
greater	great	JJR	I-NP	O
,	,	,	O	O
give	give	VB	B-VP	O
10	10	CD	B-NP	O
units	unit	NNS	I-NP	O
.	.	.	O	O

9	9	CD	B-NP	O
.	.	.	O	O

Lantus	Lantus	NNP	B-NP	O
48	48	CD	I-NP	O
units	unit	NNS	I-NP	O
at	at	IN	B-PP	O
bedtime	bedtime	NN	B-NP	O
.	.	.	O	O

10	10	CD	B-NP	O
.	.	.	O	O

Keppra	Keppra	NNP	B-NP	O
1000	1000	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
11	11	CD	I-NP	O
.	.	.	O	O

Lisinopril	Lisinopril	NNP	B-NP	O
5	5	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

12	12	CD	B-NP	O
.	.	.	O	O

Toprol-XL	Toprol-XL	NN	B-NP	O
150	150	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

13	13	CD	B-NP	O
.	.	.	O	O

Prilosec	Prilosec	RB	B-NP	O
20	20	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	RB	B-ADVP	O
daily	daily	RB	I-ADVP	O
.	.	.	O	O

14	14	CD	B-NP	O
.	.	.	O	O

Sarna	Sarna	NNP	B-NP	O
topical	topical	JJ	I-NP	O
lotion	lotion	NN	I-NP	O
q.	q.	NN	I-NP	O
2h	2h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
itching	itch	VBG	B-VP	O
.	.	.	O	O

15	15	CD	B-NP	O
.	.	.	O	O

Senna	Senna	NNP	B-NP	O
tablets	tablet	VBZ	B-VP	O
two	two	CD	B-NP	O
tabs	tab	NNS	I-NP	O
p.o.	p.o.	FW	B-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
constipation	constipation	NN	I-NP	O
.	.	.	O	O

16	16	CD	B-NP	O
.	.	.	O	O

Multivitamin	Multivitamin	NN	B-NP	O
daily	daily	RB	B-ADVP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
is	be	VBZ	B-VP	O
being	be	VBG	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehab	rehab	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
4-8323551	4-8323551	CD	B-NP	O
EMSSten	EMSSten	NNP	I-NP	O
Tel	Tel	NNP	I-NP	O
CC	CC	NNP	I-NP	O
:	:	:	O	O
Van	Van	NNP	B-NP	O
Traster	Traster	NNP	I-NP	O
M.D.	M.D.	NNP	I-NP	O
Co	Co	NNP	I-NP	O
Niberkerie	Niberkerie	NNP	I-NP	O
Mon	Mon	NNP	I-NP	O
Car	Car	NNP	I-NP	O
In	In	NNP	I-NP	O
cc	cc	NN	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Lambka	Lambka	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
GALIANO	GALIANO	NN	B-NP	O
,	,	,	O	O
JACK	JACK	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BUSHROD	BUSHROD	NN	B-NP	O
,	,	,	O	O
WILMER	WILMER	NNP	B-NP	O
ARTURO	ARTURO	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
7996578	7996578	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
3/19/06	3/19/06	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
3/19/06	3/19/06	CD	B-NP	O

